GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Meheco Group Co 600056.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

8.86

-0.78%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥35.36bn

FY2016FY2025

Net income

CN¥473.2m

FY2016FY2025

Free cash flow

CN¥1.09bn

FY2016FY2025

Shareholders' equity

CN¥11.84bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥35.36bnCN¥34.15bnCN¥38.82bnCN¥37.59bnCN¥36.23bnCN¥39.31bnCN¥35.28bnCN¥31.01bnCN¥30.36bnCN¥25.95bn
Gross profitCN¥3.71bnCN¥3.60bnCN¥4.35bnCN¥4.64bnCN¥4.69bnCN¥6.36bnCN¥6.36bnCN¥6.41bnCN¥4.37bnCN¥3.07bn
Research and developmentCN¥158.4mCN¥140.2mCN¥115.5mCN¥77.3mCN¥57.4mCN¥83.8mCN¥107.5mCN¥86.0mCN¥143.8mCN¥81.7m
Operating incomeCN¥1.17bnCN¥1.13bnCN¥1.67bnCN¥1.20bnCN¥1.38bnCN¥1.94bnCN¥1.85bnCN¥1.88bnCN¥2.06bnCN¥1.46bn
Net incomeCN¥473.2mCN¥535.5mCN¥1.05bnCN¥735.6mCN¥647.1mCN¥1.31bnCN¥981.3mCN¥1.54bnCN¥1.31bnCN¥949.7m
Diluted earnings per share0.320.360.700.490.431.230.921.451.230.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥36.87bnCN¥35.28bnCN¥37.41bnCN¥35.90bnCN¥31.11bnCN¥33.19bnCN¥29.83bnCN¥25.34bnCN¥21.19bnCN¥19.52bn
Cash and short-term investments—CN¥4.34bnCN¥3.87bnCN¥4.26bnCN¥2.80bnCN¥3.57bnCN¥2.83bnCN¥3.73bnCN¥3.34bnCN¥3.09bn
Total liabilitiesCN¥22.51bnCN¥21.17bnCN¥23.52bnCN¥22.73bnCN¥18.60bnCN¥20.97bnCN¥18.82bnCN¥15.21bnCN¥12.30bnCN¥11.84bn
DebtCN¥670.8mCN¥5.75bnCN¥5.02bnCN¥5.38bnCN¥4.69bnCN¥4.49bnCN¥3.98bnCN¥1.37bnCN¥670.4mCN¥668.9m
Shareholders' equityCN¥11.84bnCN¥11.82bnCN¥11.56bnCN¥10.82bnCN¥10.26bnCN¥10.01bnCN¥8.99bnCN¥8.45bnCN¥7.76bnCN¥6.88bn
Shares outstanding1,496m1,496m1,496m1,496m1,495m1,068m1,069m1,068m1,068m1,466m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.43bnCN¥1.01bnCN¥859.1mCN¥1.65bnCN¥148.4mCN¥1.56bn−CN¥53.8mCN¥257,807CN¥509.2mCN¥1.00bn
Capital spending−CN¥333.1m−CN¥358.6m−CN¥362.6m−CN¥229.0m−CN¥286.1m−CN¥317.7m−CN¥280.3m−CN¥261.9m−CN¥108.7m−CN¥153.7m
Free cash flowCN¥1.09bnCN¥646.8mCN¥496.5mCN¥1.42bn−CN¥137.7mCN¥1.24bn−CN¥334.2m−CN¥261.7mCN¥400.5mCN¥850.3m
Dividends paid−CN¥303.5m−CN¥510.9m−CN¥367.9m−CN¥621.5m−CN¥393.2m−CN¥294.4m−CN¥463.4m−CN¥446.4m−CN¥315.5m−CN¥239.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥8.76bnCN¥8.19bnCN¥9.47bnCN¥8.82bnCN¥8.81bnCN¥8.26bnCN¥8.05bnCN¥8.30bn
Gross profitCN¥972.7mCN¥868.8mCN¥1.02bnCN¥909.2mCN¥895.4mCN¥875.4mCN¥818.7mCN¥849.5m
Operating incomeCN¥379.8mCN¥343.5mCN¥428.1mCN¥318.4mCN¥220.2mCN¥304.7mCN¥81.0mCN¥243.9m
Net incomeCN¥66.9mCN¥182.2mCN¥18.5mCN¥160.8mCN¥127.6mCN¥166.4mCN¥88.3mCN¥122.0m
Diluted earnings per share0.040.120.010.110.090.110.060.08
Cash from operations———CN¥233.0mCN¥935.0m−CN¥1.48bnCN¥1.32bnCN¥367.0m
Capital spending−CN¥55.0m−CN¥56.0m−CN¥123.0m−CN¥84.0m−CN¥63.0m−CN¥61.0m−CN¥117.0m−CN¥80.0m
Free cash flow———CN¥149.0mCN¥872.0m−CN¥1.54bnCN¥1.21bnCN¥287.0m
Total assetsCN¥38.94bnCN¥37.48bnCN¥36.87bnCN¥36.99bnCN¥36.71bnCN¥35.69bnCN¥35.28bnCN¥37.88bn
Cash and short-term investments———CN¥2.50bnCN¥3.13bnCN¥2.90bnCN¥4.34bnCN¥2.71bn
DebtCN¥1.67bnCN¥770.5mCN¥670.8mCN¥6.83bnCN¥4.85bnCN¥7.58bnCN¥5.56bnCN¥5.23bn
Shareholders' equityCN¥11.97bnCN¥12.02bnCN¥11.84bnCN¥11.85bnCN¥11.72bnCN¥11.99bnCN¥11.82bnCN¥11.66bn

Financial ratios

Data as of 30 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin10.5%10.5%11.2%12.3%13.0%16.2%
Operating margin3.4%3.3%4.3%3.2%3.8%4.9%
Net margin1.3%1.6%2.7%2.0%1.8%3.3%
Return on equity4.0%4.5%9.1%6.8%6.3%13.1%
Return on assets1.3%1.5%2.8%2.0%2.1%3.9%
Free cash flow yield13.2%10.3%9.2%14.1%3.3%19.8%
Revenue growth3.6%-12.0%3.3%3.7%-7.8%11.4%
Earnings growth-11.6%-48.9%42.5%13.7%-50.6%33.6%
Current ratio1.42x1.54x1.58x1.50x1.64x1.46x
Debt to equity0.06x0.47x0.41x0.30x0.44x0.45x
Equity ratio32.1%33.5%30.9%30.1%33.0%30.1%
Interest coverage6.07x4.86x7.24x4.90x6.07x7.57x
R&D as a share of sales0.4%0.4%0.3%0.2%0.2%0.2%
Buybacks as a share of market value0.0%0.0%0.0%-0.0%-39.9%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.0%-2.1%5.6%
Operating income-0.7%-9.5%2.5%
Net income-13.7%-18.4%-2.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin10.5%11.2%12.4%13.7%
Operating margin3.3%3.5%3.8%4.6%
Net margin1.5%1.9%2.1%2.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings32.731.015.935.019.58.310.26.214.521.0
Price to sales0.40.50.40.70.30.30.30.30.60.8

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 26 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0750.020.2320.1480.1820.2630.1970.31
  • 7-for-5 split · 24 Jun 2022
  • 2-for-1 split · 19 Jun 2014
  • 13-for-10 split · 13 May 2010
  • 1.147-for-1 split · 13 Jun 2006
  • 8-for-5 split · 10 Jun 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.